DEUTSCHE BANK AG\ - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 38 filers reported holding SINOVAC BIOTECH LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q2 2018$1,094,000
-28.8%
146,674
-17.8%
0.00%
-100.0%
Q1 2018$1,536,000
-20.5%
178,466
-27.3%
0.00%0.0%
Q4 2017$1,933,000
+34.3%
245,328
+20.1%
0.00%0.0%
Q3 2017$1,439,000
+782.8%
204,214
+742.5%
0.00%
Q2 2017$163,000
+89.5%
24,239
+61.5%
0.00%
Q1 2017$86,000
-82.7%
15,009
-82.2%
0.00%
Q4 2016$498,000
+1.4%
84,410
+1.4%
0.00%
Q3 2016$491,000
-1.6%
83,230
-1.2%
0.00%
Q2 2016$499,000
-49.4%
84,210
-45.5%
0.00%
-100.0%
Q1 2016$987,000
+18.5%
154,616
+6.0%
0.00%0.0%
Q4 2015$833,000
+7.8%
145,867
-4.3%
0.00%0.0%
Q3 2015$773,000
-17.1%
152,369
-14.3%
0.00%0.0%
Q2 2015$932,000
+13.1%
177,697
+6.8%
0.00%0.0%
Q1 2015$824,000
-0.1%
166,308
+5.3%
0.00%0.0%
Q4 2014$825,000
+15.2%
157,983
+6.0%
0.00%
Q3 2014$716,000
-4.0%
149,099
+12.6%
0.00%
-100.0%
Q2 2014$746,000
-23.6%
132,464
-2.5%
0.00%0.0%
Q1 2014$977,000
-13.5%
135,876
-26.5%
0.00%0.0%
Q4 2013$1,130,000
-47.0%
184,947
-48.2%
0.00%
-50.0%
Q3 2013$2,134,000357,0520.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q2 2017
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,000,0007.22%
Vivo Capital, LLC 5,900,000$38,173,0004.18%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.82%
Financial Gravity Asset Management, Inc. 988$3,197,6860.04%
Yorktown Management & Research Co Inc 149,786$4,4940.01%
Renaissance Technologies 2,375,841$1,5370.00%
WELLS FARGO & COMPANY/MN 1,661$10,7470.00%
NORTHERN TRUST CORP 13,787$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$2,6660.00%
View complete list of SINOVAC BIOTECH LTD shareholders